ArticleTheranostics2021

USP32 confers cancer cell resistance to YM155 via promoting ER-associated degradation of solute carrier protein SLC35F2.

Arun Pandian Chandrasekaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.